(Q79424311)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Extracellular matrix turnover and disease severity in Anderson-Fabry disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

J S Shah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

M H Tayebjee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

R J MacFadyen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

A B Mehta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

P M Elliott

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

11 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

88-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160618%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10545-006-0360-6

22 December 2019

exact match

0 references

cites work

Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.

1 reference

12 December 2020

Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function.

1 reference

12 December 2020

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

1 reference

12 December 2020

TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension

1 reference

12 December 2020

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study

1 reference

12 December 2020

Arterial remodelling in Fabry disease

1 reference

12 December 2020

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

1 reference

12 December 2020

Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance

1 reference

12 December 2020

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

12 December 2020

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

1 reference

12 December 2020

Matrix metalloproteinases

1 reference

12 December 2020

The natural history of left ventricular systolic function in Anderson-Fabry disease.

1 reference

12 December 2020

Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.

1 reference

12 December 2020

Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of α-galactosidase A

1 reference

12 December 2020

Matrix metalloproteinases: they're not just for matrix anymore!

1 reference

12 December 2020

Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy

1 reference

12 December 2020

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

12 December 2020

Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure

1 reference

12 December 2020

The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy

1 reference

12 December 2020

Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Fabry Disease

1 reference

12 December 2020

Role of matrix metalloproteinases in normal and disease processes

1 reference

12 December 2020

Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity

1 reference

12 December 2020

Changes in collagenase and collagen gene expression after induction of aortocaval fistula in rats

1 reference

12 December 2020

Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction

1 reference

12 December 2020

Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease

1 reference

12 December 2020

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

1 reference

12 December 2020

Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy

1 reference

12 December 2020

Cardiac manifestations of Anderson-Fabry disease in heterozygous females

1 reference

12 December 2020

The heart in Fabry's disease. A histochemical and electron microscopic study

1 reference

12 December 2020

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

1 reference

12 December 2020

TIMP-2: an endogenous inhibitor of angiogenesis

1 reference

12 December 2020

The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease

1 reference

12 December 2020

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

1 reference

12 December 2020